Invesaro

Stocks Comparison

Cencora vs Humana: revenue, profit, margins and growth compared

Cencora brought in $321.3B of revenue in fiscal 2025, Humana $129.7B in fiscal 2025. Revenue changed by +9.3% at Cencora and +10.1% at Humana on the year before, so Humana grew faster. Cencora kept 0.5% of its revenue as net profit, Humana 0.9%. Free cash flow was $3.2B at Cencora and $375M at Humana.

Side by side, latest fiscal year

CORHUM
Fiscal year endedFY2025 (September 30, 2025)FY2025 (December 31, 2025)
Revenue$321.3B$129.7B
Revenue growth+9.3%+10.1%
Net income$1.6B$1.2B
Net margin0.5%0.9%
Free cash flow$3.2B$375M
Free cash flow margin1.0%0.3%
Earnings per share (diluted)$7.96$9.84
Cash$4.4B$4.2B
Debt$7.7B$12.4B
Price to earnings38.640.4
Market value$58.6B$47.8B
Dividend yield0.72%0.89%
Rank by revenue in sector#3 of 523 · Health care#8 of 523 · Health care

Over the years

Revenue
COR FY2018: $167.9BCOR FY2019: $179.6BCOR FY2020: $189.9BCOR FY2021: $214BCOR FY2022: $238.6BCOR FY2023: $262.2BCOR FY2024: $294BCOR FY2025: $321.3BHUM FY2018: $56.9BHUM FY2019: $64.9BHUM FY2020: $77.2BHUM FY2021: $83.1BHUM FY2022: $92.9BHUM FY2023: $106.4BHUM FY2024: $117.8BHUM FY2025: $129.7BFY18FY19FY20FY21FY22FY23FY24FY25
COR $321.3BHUM $129.7B
Net income
COR FY2018: $1.7BCOR FY2019: $855.4MCOR FY2020: -$3.4BCOR FY2021: $1.5BCOR FY2022: $1.7BCOR FY2023: $1.7BCOR FY2024: $1.5BCOR FY2025: $1.6BHUM FY2018: $1.7BHUM FY2019: $2.7BHUM FY2020: $3.4BHUM FY2021: $2.9BHUM FY2022: $2.8BHUM FY2023: $2.5BHUM FY2024: $1.2BHUM FY2025: $1.2BFY18FY19FY20FY21FY22FY23FY24FY25
COR $1.6BHUM $1.2B
Net margin
COR FY2018: 1.0%COR FY2019: 0.5%COR FY2020: -1.8%COR FY2021: 0.7%COR FY2022: 0.7%COR FY2023: 0.7%COR FY2024: 0.5%COR FY2025: 0.5%HUM FY2018: 3.0%HUM FY2019: 4.2%HUM FY2020: 4.4%HUM FY2021: 3.5%HUM FY2022: 3.0%HUM FY2023: 2.3%HUM FY2024: 1.0%HUM FY2025: 0.9%FY18FY19FY20FY21FY22FY23FY24FY25
COR 0.5%HUM 0.9%
Revenue growth
COR FY2019: +6.9%COR FY2020: +5.7%COR FY2021: +12.7%COR FY2022: +11.5%COR FY2023: +9.9%COR FY2024: +12.1%COR FY2025: +9.3%HUM FY2019: +14.0%HUM FY2020: +18.9%HUM FY2021: +7.7%HUM FY2022: +11.8%HUM FY2023: +14.5%HUM FY2024: +10.7%HUM FY2025: +10.1%FY19FY20FY21FY22FY23FY24FY25
COR +9.3%HUM +10.1%
Free cash flow
COR FY2018: $1.1BCOR FY2019: $2BCOR FY2020: $1.8BCOR FY2021: $2.2BCOR FY2022: $2.2BCOR FY2023: $3.5BCOR FY2024: $3BCOR FY2025: $3.2BHUM FY2018: $1.6BHUM FY2019: $4.5BHUM FY2020: $4.7BHUM FY2021: $920MHUM FY2022: $3.5BHUM FY2023: $3BHUM FY2024: $2.4BHUM FY2025: $375MFY18FY19FY20FY21FY22FY23FY24FY25
COR $3.2BHUM $375M

Fiscal years as each company reports them; the two may end in different months.

Questions about Cencora and Humana

Which is bigger by revenue, Cencora or Humana?

Cencora is bigger by revenue: $321.3B in fiscal 2025, against $129.7B for Humana in fiscal 2025.

Which keeps more of its revenue as profit, Cencora or Humana?

Cencora had a net margin of 0.5% in fiscal 2025; Humana had 0.9% in fiscal 2025.

Which grew revenue faster, Cencora or Humana?

In their latest fiscal years revenue changed by +9.3% at Cencora and +10.1% at Humana.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies